Daiwa Securities Group Inc. Clovis Oncology, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$4.06 - $5.8 $974 - $1,392	240 Added 144.58%	406 $2,000
Q4 2020 Feb 04, 2021	BUY	$4.13 - $6.41 $685 - $1,064	166 New	166 $1,000
Q4 2019 Jan 31, 2020	SELL	$3.0 - $16.43 $1,008 - $5,520	-336 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$17.66 - $30.28 $1,147 - $1,968	65 Added 23.99%	336 $8,000
Q1 2018 May 02, 2018	BUY	$50.12 - $67.72 $13,582 - $18,352	271 New	271 $14,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.